Table 13.1.
Possible sources of health indicator surveillance data
Data source | Pros | Cons and confounders |
---|---|---|
Outpatient and emergency department visits | Reflects incidence of disease in the general population | Nonspecific – may be difficult to document definitive information |
Intensive care unit diagnoses | Best indicator of rare events like west Nile virus or Hantavirus pulmonary syndrome | Will not capture milder cases |
Over-the-counter pharmacy sales | Reflects symptomatology most broadly | Subject to promotions/sales |
Clinical lab submissions | Ordered by clinicians | May not be ordered for all (most) patients |
Medicare or medicaid claims | Ease of capture data | Problems with timeliness and accuracy |
Nursing homes | Reported by medical personnel; immobile population with limited exposure possibilities | Immobility reduces exposure potential; not broadly representative |
Systematic testing for specific disease agents in specimens submitted to public health lab | Specificity of diagnoses | Broad screening not likely to capture meaningful data; difficulty getting information on positive samples; not timely |
School and work absenteeism | May occur earlier than clinician visits | Nonspecific; delays in obtaining data |
Ambulance call chief complaints | Many communities with timely access to data | Nonspecific |
Poison information center calls | Ability to access in real-time | Many not be related to infectious diseases |
HMO/nurse hotline calls | Occur very early in outbreak | May be difficult to categorize |
Reprinted with permission from Biological Threats and Terrorism: Assessing the Science and Response Capabilities: Workshop Summary © 2002 by the National Academy of Sciences, courtesy of the National Academies Press, Washington, D.C.